Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2000 Dec;55(12):1046–1051. doi: 10.1136/thorax.55.12.1046

Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy

R Schulz 1, D Schmidt 1, A Blum 1, X Lopes-Ribeiro 1, C Lucke 1, K Mayer 1, H Olschewski 1, W Seeger 1, F Grimminger 1
PMCID: PMC1745665  PMID: 11083891

Abstract

BACKGROUND—Reduced endothelium dependent vasodilation has been reported in patients with obstructive sleep apnoea (OSA) but direct measurements of the most potent naturally occurring vasodilator, nitric oxide (NO) or its derivatives (nitrate and nitrite, NOx), have not yet been performed in these patients.
METHODS—In 21 patients with OSA of mean (SE) age 54 (2) years, body mass index (BMI) 30.9 (1.1) kg/m2, and apnoea-hypopnoea index (AHI) 37 (4)/h, NOx levels were measured in peripheral venous blood samples by chemiluminescence. Blood samples were obtained before and after two nights of continuous positive airway pressure (CPAP) and after 5.5 (1.5) months of follow up. Thirteen age matched, healthy volunteers and 18 patients without OSA but with a similar spectrum of comorbidity served as controls (control groups 1 and 2).
RESULTS—Before CPAP NOx levels were 21.7 (1.5) µM in patients with OSA compared with 42.6 (2.2) µM and 36.7 (1.7) µM in control groups 1 and 2, respectively (p<0.01 for each comparison). NOx concentrations increased to 32.1 (2.7) µM after two nights of CPAP and remained constant at 32.9 (2.3) µM at follow up (p<0.01 compared with levels before CPAP).
CONCLUSIONS—Plasma NOx levels are reduced in OSA and can be increased by short and long term CPAP therapy. Although the precise mechanism underlying this observation remains to be clarified, it may have important implications for the development of cardiovascular disease in patients with OSA and for the life saving effect of CPAP.



Full Text

The Full Text of this article is available as a PDF (145.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahrén C., Jungersten L., Sandberg T. Plasma nitrate as an index of nitric oxide formation in patients with acute infectious diseases. Scand J Infect Dis. 1999;31(4):405–407. doi: 10.1080/00365549950163879. [DOI] [PubMed] [Google Scholar]
  2. Barnes P. J., Kharitonov S. A. Exhaled nitric oxide: a new lung function test. Thorax. 1996 Mar;51(3):233–237. doi: 10.1136/thx.51.3.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blum M., Yachnin T., Wollman Y., Chernihovsky T., Peer G., Grosskopf I., Kaplan E., Silverberg D., Cabili S., Iaina A. Low nitric oxide production in patients with chronic renal failure. Nephron. 1998;79(3):265–268. doi: 10.1159/000045047. [DOI] [PubMed] [Google Scholar]
  4. Carlson J. T., Rångemark C., Hedner J. A. Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens. 1996 May;14(5):577–584. doi: 10.1097/00004872-199605000-00006. [DOI] [PubMed] [Google Scholar]
  5. Cohen R. A. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog Cardiovasc Dis. 1995 Sep-Oct;38(2):105–128. doi: 10.1016/s0033-0620(05)80002-7. [DOI] [PubMed] [Google Scholar]
  6. Duchna H. W., Guilleminault C., Stoohs R. A., Faul J. L., Moreno H., Hoffman B. B., Blaschke T. F. Vascular reactivity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2000 Jan;161(1):187–191. doi: 10.1164/ajrccm.161.1.9810062. [DOI] [PubMed] [Google Scholar]
  7. He J., Kryger M. H., Zorick F. J., Conway W., Roth T. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest. 1988 Jul;94(1):9–14. [PubMed] [Google Scholar]
  8. Hedner J. Vascular function in OSA. Sleep. 1996 Dec;19(10 Suppl):S213–S217. doi: 10.1093/sleep/19.suppl_10.s213. [DOI] [PubMed] [Google Scholar]
  9. Huszka M., Kaplar M., Rejto L., Tornai I., Palatka K., Laszlo P., Udvardy M. The association of reduced endothelium derived relaxing factor-NO production with endothelial damage and increased in vivo platelet activation in patients with diabetes mellitus. Thromb Res. 1997 Apr 15;86(2):173–180. doi: 10.1016/s0049-3848(97)00060-1. [DOI] [PubMed] [Google Scholar]
  10. Jang A. S., Choi I. S. Nitric oxide metabolites in patients with asthma: induced sputum versus blood. Respir Med. 1999 Dec;93(12):912–918. doi: 10.1016/s0954-6111(99)90059-8. [DOI] [PubMed] [Google Scholar]
  11. Kelm M., Preik-Steinhoff H., Preik M., Strauer B. E. Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: evidence for biochemical assessment of the endothelial L-arginine-NO pathway. Cardiovasc Res. 1999 Mar;41(3):765–772. doi: 10.1016/s0008-6363(98)00259-4. [DOI] [PubMed] [Google Scholar]
  12. Kohno M., Yokokawa K., Minami M., Yasunari K., Maeda K., Kano H., Hanehira T., Yoshikawa J. Plasma levels of nitric oxide and related vasoactive factors following long-term treatment with angiotensin-converting enzyme inhibitor in patients with essential hypertension. Metabolism. 1999 Oct;48(10):1256–1259. doi: 10.1016/s0026-0495(99)90264-0. [DOI] [PubMed] [Google Scholar]
  13. Liao J. K., Zulueta J. J., Yu F. S., Peng H. B., Cote C. G., Hassoun P. M. Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen. J Clin Invest. 1995 Dec;96(6):2661–2666. doi: 10.1172/JCI118332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Loscalzo J., Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis. 1995 Sep-Oct;38(2):87–104. doi: 10.1016/s0033-0620(05)80001-5. [DOI] [PubMed] [Google Scholar]
  15. Marín J. Age-related changes in vascular responses: a review. Mech Ageing Dev. 1995 Apr 14;79(2-3):71–114. doi: 10.1016/0047-6374(94)01551-v. [DOI] [PubMed] [Google Scholar]
  16. McQuillan L. P., Leung G. K., Marsden P. A., Kostyk S. K., Kourembanas S. Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. Am J Physiol. 1994 Nov;267(5 Pt 2):H1921–H1927. doi: 10.1152/ajpheart.1994.267.5.H1921. [DOI] [PubMed] [Google Scholar]
  17. Node K., Kitakaze M., Yoshikawa H., Kosaka H., Hori M. Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension. Hypertension. 1997 Sep;30(3 Pt 1):405–408. doi: 10.1161/01.hyp.30.3.405. [DOI] [PubMed] [Google Scholar]
  18. Node K., Kitakaze M., Yoshikawa H., Kosaka H., Hori M. Reversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adults. Am J Cardiol. 1997 Jun 1;79(11):1538–1541. doi: 10.1016/s0002-9149(97)00189-6. [DOI] [PubMed] [Google Scholar]
  19. Partinen M., Jamieson A., Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Mortality. Chest. 1988 Dec;94(6):1200–1204. doi: 10.1378/chest.94.6.1200. [DOI] [PubMed] [Google Scholar]
  20. Peker Y., Hedner J., Johansson A., Bende M. Reduced hospitalization with cardiovascular and pulmonary disease in obstructive sleep apnea patients on nasal CPAP treatment. Sleep. 1997 Aug;20(8):645–653. doi: 10.1093/sleep/20.8.645. [DOI] [PubMed] [Google Scholar]
  21. Ranjan V., Xiao Z., Diamond S. L. Constitutive NOS expression in cultured endothelial cells is elevated by fluid shear stress. Am J Physiol. 1995 Aug;269(2 Pt 2):H550–H555. doi: 10.1152/ajpheart.1995.269.2.H550. [DOI] [PubMed] [Google Scholar]
  22. Schulz R., Mahmoudi S., Hattar K., Sibelius U., Olschewski H., Mayer K., Seeger W., Grimminger F. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):566–570. doi: 10.1164/ajrccm.162.2.9908091. [DOI] [PubMed] [Google Scholar]
  23. Spriestersbach R., Grimminger F., Weissmann N., Walmrath D., Seeger W. On-line measurement of nitric oxide generation in buffer-perfused rabbit lungs. J Appl Physiol (1985) 1995 Apr;78(4):1502–1508. doi: 10.1152/jappl.1995.78.4.1502. [DOI] [PubMed] [Google Scholar]
  24. Tanaka S., Yashiro A., Nakashima Y., Nanri H., Ikeda M., Kuroiwa A. Plasma nitrite/nitrate level is inversely correlated with plasma low-density lipoprotein cholesterol level. Clin Cardiol. 1997 Apr;20(4):361–365. doi: 10.1002/clc.4960200412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tsikas D., Gutzki F. M., Rossa S., Bauer H., Neumann C., Dockendorff K., Sandmann J., Frölich J. C. Measurement of nitrite and nitrate in biological fluids by gas chromatography-mass spectrometry and by the Griess assay: problems with the Griess assay--solutions by gas chromatography-mass spectrometry. Anal Biochem. 1997 Jan 15;244(2):208–220. doi: 10.1006/abio.1996.9880. [DOI] [PubMed] [Google Scholar]
  26. Viinikka L. Nitric oxide as a challenge for the clinical chemistry laboratory. Scand J Clin Lab Invest. 1996 Nov;56(7):577–581. doi: 10.3109/00365519609090591. [DOI] [PubMed] [Google Scholar]
  27. Weiss J. W., Launois S. H., Anand A., Garpestad E. Cardiovascular morbidity in obstructive sleep apnea. Prog Cardiovasc Dis. 1999 Mar-Apr;41(5):367–376. doi: 10.1053/pcad.1999.0410367. [DOI] [PubMed] [Google Scholar]
  28. Wright J., Johns R., Watt I., Melville A., Sheldon T. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence. BMJ. 1997 Mar 22;314(7084):851–860. doi: 10.1136/bmj.314.7084.851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Yagi M., Adachi J., Tatsuno Y., Mizuno K. Change in nitric oxide in humans due to application of a pneumatic tourniquet. Clin Chim Acta. 1998 Nov;278(1):67–74. doi: 10.1016/s0009-8981(98)00156-9. [DOI] [PubMed] [Google Scholar]
  30. Ziegler T., Bouzourène K., Harrison V. J., Brunner H. R., Hayoz D. Influence of oscillatory and unidirectional flow environments on the expression of endothelin and nitric oxide synthase in cultured endothelial cells. Arterioscler Thromb Vasc Biol. 1998 May;18(5):686–692. doi: 10.1161/01.atv.18.5.686. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES